This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Pregabalin: Difference between revisions
Jump to navigation
Jump to search
>BronzeManul Reduced oral minimum common dose and oral max light dose from 300mg to 225mg and reduced oral minimum light dose from 150mg to 75mg. |
>BronzeManul Increased oral minimum total duration from 6 to 8 hours and added oral peak, offset, and after effects duration ranges. |
||
| Line 78: | Line 78: | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
|OralROA_Duration=[[Oral min total time:: | |OralROA_Duration=[[Oral min total time::8]] - [[Oral max total time::14]] [[Oral total time units::hours]] | ||
|OralROA_Onset=[[Oral min onset time::40]] - [[Oral max onset time::120]] [[Oral onset time units::minutes]] | |OralROA_Onset=[[Oral min onset time::40]] - [[Oral max onset time::120]] [[Oral onset time units::minutes]] | ||
|OralROA_Peak= | |OralROA_Peak=[[Oral min peak time::4]] - [[Oral max peak time::6]] [[Oral peak time units::hours]] | ||
|OralROA_Offset= | |OralROA_Offset=[[Oral min offset time::4]] - [[Oral max offset time::8]] [[Oral offset time units::hours]] | ||
|OralROA_Aftereffects= | |OralROA_Aftereffects=[[Oral min afterglow time::4]] - [[Oral max afterglow time::10]] [[Oral afterglow time units::hours]] | ||
}} | }} | ||
Revision as of 07:53, 31 July 2018
| SubstanceBox/Pregabalin | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||||||||||
| Common names | Pregabalin, Lyrica, Nervalin | ||||||||||||||||||||||||||||||||
| Substitutive name | 3-Isobutyl GABA | ||||||||||||||||||||||||||||||||
| Systematic name | (S)-3-(Aminomethyl)-5-methylhexanoic acid | ||||||||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||||||||
| Psychoactive class | Depressant | ||||||||||||||||||||||||||||||||
| Chemical class | Gabapentinoid | ||||||||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||